Business · 12/12/1995
FDA Affirms GRAS Status of Glyceryl Palmitostearate
The FDA is amending its regulations to confirm that glyceryl palmitostearate is generally recognized as safe for use as a formulation aid in tablets, in response to a petition from Gattefosse, S.A.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →